-
ADS
-
ADS
-
ADS
-
ADS
-
Bone marrow cancer drug shows success in treatment of blood disorder, finds study
The New England Journal of Medicine published the trial results, which show that patients with HHT who were administered the medication, pomalidomide, had a significant decrease in the intensity of nosebleeds, required fewer blood transfusions and iron infusions than HHT frequently requires, and had a better quality of life.
User Feedback
-
ADS